{
    "nct_id": "NCT05848141",
    "official_title": "Indoor Rowing as a Novel Exercise Therapy for Cardiovascular Rehabilitation in Middle-Aged and Older Breast Cancer Survivors Following Chemotherapy",
    "inclusion_criteria": "* diagnosis of primary invasive non-metastatic breast cancer, stages I-III\n* female based on biological sex\n* 40 to 80 years of age\n* completed breast cancer treatment 6 to 24 months prior to study enrollment. Adjuvant endocrine therapy for breast cancer (e.g., ovarian suppression, SERMs, SERDs, AIs), CDK4/6 inhibitors, PARP inhibitors, HER2 targeted agents, immunotherapy and bisphosphonates are allowed within 6 months prior to study enrollment and during study participation\n* absence of contraindications to exercise or study participation\n* study clinician approval\nHealthy volunteers allowed\nMust be FEMALE\nMust have minimum age of 40 Years\nMust have maximum age of 80 Years",
    "exclusion_criteria": "* do not meet inclusion criteria\n* receiving or scheduled to receive treatment for breast cancer (i.e., chemotherapy, surgery, or radiation) during study participation is not allowed. Adjuvant endocrine therapy, CDK4/6 inhibitors, PARP inhibitors, HER2 targeted agents, immunotherapy and bisphosphonates are allowed during study participation\n* lymphedema stage ≥ 2 prior to study enrolment\n* any relevant cardiovascular diseases (stroke, heart failure, myocardial ischemia during maximal graded exercise test, myocardial infarction, angina pectoris, coronary artery bypass surgery or angioplasty or coronary stent)\n* current participation in other experimental interventions that may confound interpretation of study findings (e.g., dietary intervention for weight loss)\n* consistent participation in ≥150 min/week of moderate-intensity rowing exercise training in previous 6 months",
    "miscellaneous_criteria": ""
}